Key Record Dates
ClinicalTrials.gov Identifier: | NCT02954874 |
---|---|
Brief Title: | Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer |
First Submitted : | November 3, 2016 |
First Submitted that Met QC Criteria : | November 3, 2016 |
First Posted : | November 4, 2016 (Estimate) |
Last Update Submitted that Met QC Criteria : | April 17, 2021 |
Last Update Posted : | April 20, 2021 (Estimate) |